Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevikar vs Perindopril/Amlodipine in Moderate to Severe Hypertension
NCT01101009Phase 4Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Apr 2010
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of olmesartan medoxomil + amlodipine in hypertension (HTN), sponsored by Daiichi Sankyo Co., Ltd.. Started Apr 2010; status: completed.
02
Drugs
olmesartan medoxomil + amlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01101009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01101009.